The Collier Report of U.S. Government Contracting

Old School Reporting Using Modern Technology

Jeiven Pharmaceutical Consulting Inc

  • Jeiven Pharmaceutical Consulting Inc

  • View government funding actions
  • Scotch Plains, NJ 07076
  • Phone: 908-233-4508
  • Estimated Number of Employees: 12
  • Estimated Annual Receipts: $4,000,000
  • Business Start Date: 1988
  • Contact Person: Faye Varsolona
  • Contact Phone: 908-233-4508
  • Contact Email: fvarsolona@jeiven.com
  • Business Structure:
  • Corporate Entity (Not Tax Exempt)
  • Business Type:
  • For Profit Organization
  • Industries Served: Medicinal and Botanical Manufacturing, Pharmaceutical Preparation Manufacturing, In-Vitro Diagnostic Substance Manufacturing, Biological Product (except Diagnostic) Manufacturing, Process, Physical Distribution, and Logistics Consulting Services, Other Management Consulting Services, Other Scientific and Technical Consulting Services, All Other Professional, Scientific, and Technical Services, Employment Placement Agencies, Packaging and Labeling Services, Professional and Management Development Training
  • Product Areas: LIFE SCIENCES (BASIC), R&D- GENERAL SCIENCE/TECHNOLOGY: LIFE SCIENCES (BASIC RESEARCH), R&D- GENERAL SCIENCE/TECHNOLOGY: LIFE SCIENCES (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT), LIFE SCIENCES (APPLIED/EXPLORATORY), R&D- GENERAL SCIENCE/TECHNOLOGY: LIFE SCIENCES (ADVANCED DEVELOPMENT), LIFE SCIENCES (ADVANCED), R&D- MEDICAL: BIOMEDICAL (BASIC RESEARCH), BIOMEDICAL (BASIC), R&D- MEDICAL: BIOMEDICAL (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT), BIOMEDICAL (APPLIED/EXPLORATORY), BIOMEDICAL (ADVANCED), R&D- MEDICAL: BIOMEDICAL (ADVANCED DEVELOPMENT), R&D- MEDICAL: BIOMEDICAL (ENGINEERING DEVELOPMENT), BIOMEDICAL (ENGINEERING), R&D- MEDICAL: BIOMEDICAL (OPERATIONAL SYSTEMS DEVELOPMENT), BIOMEDICAL (OPERATIONAL), R&D- MEDICAL: BIOMEDICAL (MANAGEMENT/SUPPORT), BIOMEDICAL (MANAGEMENT/SUPPORT), R&D- MEDICAL: BIOMEDICAL (COMMERCIALIZED), R&D-BIOMEDICAL-COMERCLIZ, R&D- MEDICAL: AIDS RESEARCH (OPERATIONAL SYSTEMS DEVELOPMENT), AIDS RESEARCH (OPERATIONAL), R&D- MEDICAL: AIDS RESEARCH (MANAGEMENT/SUPPORT), AIDS RESEARCH (MANAGEMENT/SUPPORT), OTHER MEDICAL (BASIC), R&D- MEDICAL: OTHER (BASIC RESEARCH), R&D- MEDICAL: OTHER (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT), OTHER MEDICAL (APPLIED/EXPLORATORY), R&D- MEDICAL: OTHER (ADVANCED DEVELOPMENT), OTHER MEDICAL (ADVANCED), OTHER MEDICAL (ENGINEERING), R&D- MEDICAL: OTHER (ENGINEERING DEVELOPMENT), R&D- MEDICAL: OTHER (OPERATIONAL SYSTEMS DEVELOPMENT), OTHER MEDICAL (OPERATIONAL), R&D- MEDICAL: OTHER (MANAGEMENT/SUPPORT), OTHER MEDICAL (MANAGEMENT/SUPPORT), R&D-OTHER MEDICAL-COMERCLIZ, R&D- MEDICAL: OTHER (COMMERCIALIZED), R&D-OTHER R & D-B RES, R&D- OTHER RESEARCH AND DEVELOPMENT (BASIC RESEARCH), R&D- OTHER RESEARCH AND DEVELOPMENT (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT), R&D-OTHER R & D-A RES/EXPL DEV, R&D- OTHER RESEARCH AND DEVELOPMENT (ADVANCED DEVELOPMENT), R&D-OTHER R & D-ADV DEV, R&D-OTHER R & D-ENG DEV, R&D- OTHER RESEARCH AND DEVELOPMENT (ENGINEERING DEVELOPMENT), R&D- OTHER RESEARCH AND DEVELOPMENT (OPERATIONAL SYSTEMS DEVELOPMENT), R&D-OTHER R & D-OPSY DEV, R&D-OTHER R & D-MGMT SUP, R&D- OTHER RESEARCH AND DEVELOPMENT (MANAGEMENT/SUPPORT), R&D-OTHER R & D-COMERCLIZ, R&D- OTHER RESEARCH AND DEVELOPMENT (COMMERCIALIZED)

Sampling of Federal Government Funding Actions/Set Asides

In order by amount of set aside monies.

  • $10,764 - Monday the 18th of April 2016
    Office Of Assistant Secretary For Administration
    PHA CO, PHS, SSC, PERRY POINT MD
    TRAINING FOR SUBMISSION GATEWAY

© Copyright 2019
The Collier Report
published by 1918 Media LLC.
Information displayed in this dossier has been provided through available open source or public sources. No reliance should be made by readers or Collier Report subscribers. Funding actions are complicated and do not always represent dollar-for-dollar payments to vendors nor do they represent payments in certain instances. Requests for the modification of displayed information may be made to help.desk@1918.media.